Future Health and Bridge for Billions Launch Programme to Scale Health Innovation Across Emerging Markets Future Health, a global initiative by Abu Dhabi, is partnering with Bridge for Billions to launch a new entrepreneurship programme aimed at strengthening promising healthcare…
Shionogi to Present New Fetroja®/Fetcroja® Data at IDWeek 2026 Highlighting Early Treatment Outcomes and Activity Against Drug-Resistant Gram-Negative Bacteria Shionogi & Co., Ltd., headquartered in Osaka, Japan, and led by Chief Executive Officer Isao Teshirogi, Ph.D., will present new clinical…
Savillex Completes Acquisition of Entegris Life Sciences Fluid Management Business to Expand Single-Use Bioprocessing Portfolio Savillex, LLC, a leading provider of high-purity fluid handling solutions for life sciences and laboratory applications worldwide, has completed its acquisition of Entegris, Inc.’s Life…
Neurogene to Present New NGN-401 Gene Therapy Data for Rett Syndrome at ESGCT 2026 Neurogene Inc., a clinical-stage biotechnology company focused on developing genetic medicines for rare neurological diseases, announced that it will present new data from its NGN-401 gene…
Baszucki Group Funds UAB Study Evaluating Ketogenic Therapy for Bipolar Disorder in Rural Alabama Baszucki Group has announced funding for a new clinical study investigating the potential psychiatric and metabolic effects of ketogenic therapy in people living with bipolar disorder…
Kazmira Therapeutics Partners With CareValidate to Expand Access to Prescription, THC-Free CBD Therapy Across the U.S. Kazmira Therapeutics, the company behind Kazmira Pharmacy and the Cope Now telehealth platform, has announced a partnership with CareValidate, a digital health infrastructure provider…
GC Biopharma to Present New IVIG Product Analyses and Host Patient Advocacy Symposium at IgNS 2026 Conference GC Biopharma USA, Inc., a company specializing in plasma-derived products, has announced plans to present two new scientific analyses and host a patient…
Stoke Therapeutics Presents STK-002 Preclinical and Clinical Data at AAO 2026, Advancing RNA-Based Approach for Autosomal Dominant Optic Atrophy Stoke Therapeutics, Inc., a biotechnology company focused on restoring protein expression by harnessing the body’s potential with RNA medicine, has announced…
Corcym Reports Positive Seven-Year Mid-Term Data for Perceval Plus Sutureless Aortic Valve in MANTRA Clinical Study Corcym, a global medical device company focused on cardiac surgery, has announced positive mid-term clinical findings from a sub-analysis of its MANTRA clinical study…
INBRAIN Neuroelectronics Completes MINIGRAPH Project, Advancing Graphene-Based Brain-Computer Interfaces and Robotic Neural Implantation INBRAIN Neuroelectronics, a clinical-stage neurotechnology company developing graphene-based brain-computer interface (BCI) therapeutics, has announced the successful completion and results of MINIGRAPH, a European Innovation Council (EIC)-funded research…
Bridge Neurotech Emerges from Stealth with Non-Invasive Brain-Computer Interface Vision, Partners with Butterfly Network Bridge Neurotech, a company developing a completely non-invasive brain-computer interface (BCI), has emerged from stealth with a mission to explore brain-computer interaction without the need for…
RoslinCT Secures Up to £7.25 Million Scottish Enterprise Grant to Accelerate Digital Transformation of Cell Therapy Manufacturing RoslinCT, a global Contract Development and Manufacturing Organization (CDMO) specializing in advanced cell therapies, has been awarded a Research & Development grant from…